Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-15 Sale | 2023-05-17 4:29 pm | REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer | 640 | $83.15 | $53,214 | 39,491 (Direct) | View |
| 2023-03-07 Sale | 2023-03-08 4:56 pm | REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer | 3,961 | $83.46 | $330,585 | 40,131 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 4:40 pm | REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer | 27,813 | $85.13 | $2,367,716 | 69,092 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-02 Exercise | 2023-03-06 4:40 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer | 25,000 | $27.32 | 69,092 (Direct) | View |
| 2023-03-02 Exercise | 2023-03-06 4:40 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer | 25,000 | $0 | 69,092 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:48 pm | N/A 2033-01-03 | REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer | 59,494 | $0 | 94,643 (Direct) | View |
Ownership | 2022-02-07 4:11 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer | 0 | $0 | 115,249 (Direct) | View |